Woolfson Eye Institute
Clinical trials sponsored by Woolfson Eye Institute, explained in plain language.
-
Shorter UV light may halt corneal disease just as well as longer exposure
Disease control Recruiting nowThis study tests a non-FDA-approved treatment called corneal crosslinking (CXL) for people with keratoconus and similar conditions that cause the cornea to thin and bulge, blurring vision. Participants receive vitamin B2 eye drops followed by either 18 or 24 minutes of UVA light …
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New hope for down syndrome vision loss: Eye-Strengthening light therapy in trials
Disease control Recruiting nowThis study tests an experimental treatment called corneal crosslinking (CXL) for people with Down syndrome who have a condition that makes the front of the eye thin and misshapen, causing blurry vision. The treatment uses vitamin B2 eye drops and ultraviolet light to strengthen t…
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated May 26, 2026 12:04 UTC